Wearable Devices and Biomarkers Project (Healthiomics)

Description

The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.

Conditions

Brain Cancer, Neurological Disorder, Neurological Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.

Study of Clinical Biomarkers in Human Health and Disease (Healthiomics)

Wearable Devices and Biomarkers Project (Healthiomics)

Condition
Brain Cancer
Intervention / Treatment

-

Contacts and Locations

San Diego

CureScience Institute, San Diego, California, United States, 92121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
  • * Participant is ≥ 18 years of age.
  • * Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
  • * Participant is characterized by at least one of the following criteria:
  • 1. Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR
  • 2. Has a neurological disorder, or is under evaluation for a possible diagnosis of a neurological disorder; OR
  • 3. Does not meet the characteristic of either a. or b. above. This participant would be considered a "healthy control" for cancer and neurological disorders.
  • * Participant or participant's legally authorized representative is unable to provide informed consent.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

CureScience,

Feng Lin, MD PhD, PRINCIPAL_INVESTIGATOR, CureScience

Study Record Dates

2025-12-31